Pfizer Canada makes investment in developing therapeutic treatments

06-06-2018

Pfizer Canada makes investment in developing therapeutic treatments

mironovak / iStockphoto.com

Pfizer Canada has announced a C$1.2 million (US$931,000) investment for the Neomed Institute in an effort to accelerate transforming scientific discoveries from Canadian universities into innovative therapeutic treatments. 


Neomed Institute, Pfizer, Pfizer Canada, therapeutic treatments, scientific discoveries, commercialisation

LSIPR